Biotech · Private company
Mediar Therapeutics
Track this companyFree. Adds Mediar Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- MTX-463Phase 2 · Idiopathic Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- MTX-474Phase 2 · Diffuse Cutaneous Systemic SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- MTX-463Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- MTX-463Phase 1 · Healthy Adult MaleClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)PHASE2 · RECRUITING · started Apr 16, 2026ClinicalTrials.gov NCT07287670 · fetched Nov 12, 2026
- Evaluation of MTX-463 Administered Subcutaneously in Healthy Adult MalesPHASE1 · COMPLETED · started Feb 18, 2026ClinicalTrials.gov NCT07450521 · fetched Nov 12, 2026
- WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)PHASE2 · ACTIVE_NOT_RECRUITING · started May 5, 2025ClinicalTrials.gov NCT06967805 · fetched Nov 12, 2026
- A First-in-Human Safety Trial of MTX-463PHASE1 · COMPLETED · started Apr 15, 2024ClinicalTrials.gov NCT06401213 · fetched Nov 12, 2026